Regeneron Pharmaceuticals | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Regeneron Pharmaceuticals

An SI Board Since May 1996

Posts	SubjectMarks	Bans	Symbol
3561	104	0	REGN

Emcee: Patrick Slevin	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
1135	Very good data...Hopefully we will be in 20's from now:-)	dr.praveen	-	10/30/2006
1134	Regeneron Reports Positive Phase 3 Data for IL-1 Trap in CAPS Monday October 30,	nigel bates	-	10/30/2006
1133	you asked for new stuff..... you did NOT ask that I know anything about its r	scaram(o)uche	-	10/26/2006
1132	>>Any hard evidence that Antisoma VTA candidate will be able to compete..&	nigel bates	-	10/26/2006
1131	Combination make sense. Any hard evidence that Antisoma VTA candidate will be a	Miljenko Zuanic	-	10/25/2006
1130	Nature Reviews Cancer 6, 833 (November 2006) Angiogenesis: Blunting the spikes	scaram(o)uche	-	10/24/2006
1129	<i>Never have seen deal terms quite like this</i> Pretty sweet deal	Biomaven	-	10/20/2006
1128	<<I could see your 12-24 month sale being a good call and I think keeping	Miljenko Zuanic	-	10/19/2006
1127	Yes, cost sharing is bit confusing. While it is global development plan, it may	Miljenko Zuanic	-	10/19/2006
1126	At the end of the day all that matters is does the drug work well and what were	rkrw	-	10/19/2006
1125	Market response was mute because: 1. Investors are "half blind" 2. The	Miljenko Zuanic	-	10/19/2006
1124	On number 4, there is a penalty since Bayer has to provide 6-12 months notice. T	rkrw	-	10/19/2006
1123	anor is a canadian company!	rkrw	-	10/19/2006
1122	Why the tepid market response to the Bayer deal? Despite the superb data from an	DewDiligence_on_SI	-	10/19/2006
1121	>> with only a little bit more luck << That's not fair. They h	scaram(o)uche	-	10/19/2006
1120	Except that pharma is getting more desperate for new product, and the terms of t	nigel bates	-	10/19/2006
1119	They keep it around to drive MZ nuts. :-) Sort of like xoma-east, with only a	scaram(o)uche	-	10/19/2006
1118	Could ask your question every time a pharma does a major deal with a bio. Yet ve	rkrw	-	10/19/2006
1117	Is there a reason it couldn't be ? (For Bayer.)	nigel bates	-	10/19/2006
1116	Thanks ya'll for discussing this..wonder if worth my picking up some more? e	zeta1961	-	10/19/2006
1115	Who says buying regn was an option?	rkrw	-	10/19/2006
1114	No US rights at all ? Why didn't they buy REGN instead ? Unless they are t	nigel bates	-	10/19/2006
1113	Never have seen deal terms quite like this. 8K Entry into a Material Definiti	rkrw	-	10/19/2006
1112	No, stayed home to trade. So I know nada re. preclinical or the quality of anti	scaram(o)uche	-	10/19/2006
1111	(duplicate post)	scaram(o)uche	-	10/19/2006

Go to reply# or date (mm/dd/yy):